Page 969 - Cardiac Nursing
P. 969

LWBK340-ind_p941-958.qxd  7/1/09  10:37 AM  Page 945 Aptara
         LWB K34 0-i nd_ p94 1-9 58. qxd   7 / 1 / 09   10 :37  AM   P a g e  94 5 A pta ra





                                                                                                             Index 945

                      HEAD     n                     #HIROPRACTY       3EE ALSO #HIROPRACTIC MEDICINE  LEGAL ASPECTS OF
                      HEART     n                    #HOLESTEROL                         MANIPULATIVE AND BODY BASED PRACTICES

                      JUGULAR VENOUS PULSE     n        F  AND ENDOTHELIAL FUNCTION OF       MEDITATION
                      LUNGS     n                      RANDOMIZED CLINICAL TRIALS FOR LOWERING     T  MELATONIN
                      PERIPHERAL VASCULAR SYSTEM     n      #HORDAE TENDINEAE            NURSING MANAGEMENT OF
                            n                        #HROMOSOME    D                     NUTRACEUTICALS AND DIETARY APPROACH OF
                   #ARDIOVASCULAR RISK FACTORS     T  #HRONIC DISEASES                           n
                   #ARDIOVASCULAR RISK PROTECTION       SELF MANAGEMENT MODEL            PATIENT DISCLOSURE OF
                   #ARDIO7EST TOTAL ARTIFICIAL HEART     F  #HRONIC /BSTRUCTIVE 0ULMONARY $ISEASE  PREVALENCE OF     n

                   #AROTID PULSE                             #/0$                        4AI #HI
                   #ATECHOLAMINERGIC 0OLYMORPHIC 6ENTRICULAR  #HRONIC VENOUS INSUFFICIENC        USE FOR CARDIOVASCULAR HEALTH
                         4ACHYCARDIA  #604           #IGARETTE $EPENDENCE 3CALE  #$3           USE IN SPECIFIC POPULATION     n
                   #ATECHOLAMINERGIC 064          F  #IRCADIAN CYCLE                     YOGA

                   #ATECHOLAMINES    n                 FOR SLEEP     n                 #OMPLEMENTARY AND ALTERNATIVE THERAPIES
                   #ATHETER ABLATION                 #IRCADIAN RHYTHM SLEEP DISORDERS     D  #OMPLEMENTARY MEDICINE
                     COMPLICATIONS                   #IRCULATORY ASSIST DEVICES     n     3EE ALSO )NTRA   #OMPLETE BLOOD CELL  #"#      n
                     DEFINITION OF     D                    AORTIC BALLOON PUMP  )!"0   ,EFT  #OMPLETE 4RANSPOSITION OF THE 'REAT !RTERIES
                     INDICATION     n        F              VENTRICULAR ASSIST DEVICE  ,6!$    #'4!




                      ATRIAL ARRHYTHMIAS     n        F  ARTIFICIAL HEART     n        F  DESCRIPTION     n        F
                      ATRIAL FIBRILLATION     n        COMPLICATION                      MANAGEMENT
                      ATRIAL FLUTTE                    CONTINUOUS FL W DEVICES     n     PATHOPHYSIOLOGY
                      !6 NODAL REENTRANT TACHYCARDIA     n     INDICATIONS FOR         #OMPUTED TOMOGRAPHY  #4
                      !6 REENTRANT TACHYCARDIA     n     LONG TERM     n                 DIAGNOSTIC INDICATIONS FOR
                      VENTRICULAR TACHYCARDIA          MECHANISM OF     n                PATIENT PREPARATION FOR     n
                     RADIOFREQUENCY                    VENTRICULAR RECOVERY OF         #ONCORDANCE  IN ADHERENCE
                     TECHNIQUES                      #IRCULATORY INTEGRITY             #ONDUCTION BLOCKS
                     WITH VENTRICULAR ARRHYTHMIAS     D  OF ACCESS SITE     n            DECREMENTAL CONDUCTION
                   #ATHETERIZATION  CARDIAC  3EE #ARDIAC  #IRCUS -OVEMENT 4ACHYCARDIA  #-4           F  PHASE   BLOCK

                         CATHETERIZATION             #+    3EE #REATINE +INASE ""  #+ ""   PHASE   BLOCK
                   #ATHETER RELATED BLOOD STREAM INFECTION  #2 "3)    #+    3EE #REATINE +INASE --  #+ --   REENTRY OF     n
                                 T                   #+    3EE #REATINE +INASE --  #+ --   #ONDUCTION TISSUES   n

                   #ATHETER TRANSDUCER SYSTEM REFLECT          F  #LASSIC  EFFORT  ANGINA       #ONGENITAL AORTIC STENOSIS
                   #AUDAL VENTROLATERAL MEDULLA  #6,-     F  #LOSTRIDIUM DIFFICIL INFECTION       CLINICAL MANIFESTATION OF     n
                   #ELL                              #LOTTING DISORDERS  3EE ALSO #OAGULATION  DESCRIPTION OF          F

                     MYOCARDIAL STRUCTURE OF    n      CLOT FORMATION IN                 MANAGEMENT OF
                   #ENTRAL CYANOSIS                    DEEP VEIN THROMBOSIS IN     n     PATHOPHYSIOLOGY OF
                   #ENTRAL NERVOUS SYSTEM              HEPARIN INDUCED THROMBOCYTOPENIA     n     #ONGENITAL HEART DISEASE

                     IN BLOOD PRESSURE REGULATION      PULMONARY EMBOLISM     n          !TRIAL SEPTAL DEFECTS  !3$           F
                                       D
                   #ENTRAL 3LEEP !PNEA  #3!      D       #LUBBING          F             CATEGORIZATION OF HEART EFFECTS          F

                                       D


                   #ENTRAL VENOUS /   SATURATION  3CVO         n     #OAGULATION         CONTRACTION OF AORTA     n        F
                   #ENTRAL VENOUS PRESSURE  #60        ACTIVATED CLOTTING TIME           ELECTROPHYSIOLOGY TESTING     D
                     VS  CARDIAC OUTPUT    n           AGENTS USED TO PROMOTE     T      HEART CATEGORIZATION IN          F

                     DIFFERENCE BETWEEN FLUID ESPONDENT AND NON  CASCADE     n        F  INCIDENCE


                         RESPONDENT     T              DRUGS USED FOR PROMOTION OF     T  PATENT DUCTUS ARTERIOSUS     n        F
                     MONITORING                        FIBRINOGEN     n                  PREVALENCE

                      COMPLICATIONS                    INFLAMMATION     n                VENTRICULAR SEPTAL DEFECTS     n        F
                      EFFECT OF CATHETER TYPE AND LOCATION       INTRAVASCULAR  DISEASES ASSOCIATED WITH     D  #ONGENITALLY #ORRECTED 4RANSPOSITION OF THE 'REAT
                      INDICATIONS                      LABORATORY TESTS FOR     T             !RTERIES  ##4'!
                      INTERPRETATION OF DATA           PARTIAL THROMBOPLASTIN TIME  044        CLINICAL MANIFESTATION OF

                      LIMITATIONS     n                PLATELET COUNT     n              DESCRIPTION          F
                      MEASUREMENT TECHNIQUE            PROTEIN #                         MANAGEMENT     n

                      PRESSURE FROM     F              PROTEINS     T                    PATHOPHYSIOLOGY
                     PROTOCOL FOR OBTAINING     D      PROTEIN 3                       #ONGESTIVE HEART FAILURE  #(&      T  3EE ALSO
                     RELATION OF 0! PRESSURE AND     D  PROTHROMBIN TIME  04                  (EART FAILURE
                     RESPIRATORY VARIATION IN        #OCKCROFT 'AULT EQUATION            KEY FEATURES OF SUCCESSFUL PROGRAMS OF CARE IN
                     SYSTEM                          #ODONS        D                             D
                   #EREBROSPINAL FLUID  #3&          #OENZYME 1                        #ONSTRICTIVE PERICARDITIS
                   #%40 INHIBITOR                    #OGNITIVE BEHAVIORAL MODEL          F  #ONSUMPTIVE COAGULOPATHY

                   #HAOTIC !4  3EE -ULTIFOCAL !TRIAL 4ACHYCARDIA  #OLLATERAL CIRCULATION      #ONTINUOUS CARDIAC OUTPUT  ##/
                          -!4                        #OLOR $OPPLER          F                    n

                   #HEMORECEPTORS                    #OMBINED DYSLIPIDEMIAS            #ONTINUOUS ENDOTHELIUM OF SKIN        F

                   #HEST DISCOMFORT                  #/ MONITORING                     #ONTINUOUS POSITIVE AIRWAY PRESSURE  #0!0
                     DIAGNOSIS OF                      $OPPLER ULTRASOUND     n        #ONTINUOUS 26 END DIASTOLIC VOLUME  #%$6
                     GOALS                             ECHOCARDIOGRAPHY     n

                     INTERVENTION     n                )#' IN     n                    #ONTINUOUS WAVE $OPPLER          F    F
                                                                                                              F
                                                                                                              F

                     OUTCOME CRITERIA                  LESS INVASIVE METHOD FOR     n     #ONTRACTILITY
                                        F

                                        F
                   #HEST RADIOGRAPHY     n        Fn   F  #OMPARTMENT SYNDROME           OF CARDIAC MUSCLES



                                                                                                      F
                                                                                                      F
                                   F
                                      F
                     IN ACUTE CARE          Fn   F    T  #OMPENSATORY METABOLIC ACIDOSIS       OF CARDIAC OUTPUT    F
                                      F
                                   F

                                          F
                                          F

                     IN CARDIOVASCULAR DISEASE          Fn   F  #OMPENSATORY RESPIRATORY ACIDOSIS       IN MYOCARDIAL OXYGEN CONSUMPTION

                     DIFFERENTIAL DIAGNOSIS OF PAIN     T  #OMPLEMENTARY AND ALTERNATIVE MEDICINE  #!-   #ONTRACTION ALKALOSIS
                     INTERPRETATION OF     n        F  CHARACTERISTICS DEFINITIONS      #ONTRAST ECHO     n        F



                             T
                             T
                     VIEWS FOR     T     F             DOMAINS          T              #ONTRAST INDUCED NEPHROPATHY
                   #HEYNE 3TOKE BREATHING              ENERGY THERAPIES IN     n       #ONUS ARTERIOSUS
                   #HIROPRACTIC MEDICINE     n         INTEGRATION INTO NURSING ASSESSMENT IN       #ONUS BRANCH    n
   964   965   966   967   968   969   970   971   972   973   974